1365 An active site PTPN2/N1 small molecule inhibitor promotes anti-tumor efficacy by sensitizing tumor cells to inflammatory signals and enhancing immune cell activity

Kathleen A. McGuire, Philip R. Kym, Prasanthi Geda et al.|Regular and Young Investigator Award Abstracts|2022

Cited by 1